TSCAN THERAPEUTICS, INC. (TCRX) Net margin 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1256.8%FY2025 · since FY2020: -2408.0% → -1256.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1256.8% | +3270.8 pp |
| FY2024 | -4527.7% | -4103.8 pp |
| FY2023 | -423.9% | +65.4 pp |
| FY2022 | -489.3% | -9.8 pp |
| FY2021 | -479.5% | +1928.5 pp |
| FY2020 | -2408.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRX financial trends
TCRX RevenueTCRX Net incomeTCRX Gross profitTCRX Gross marginTCRX Operating incomeTCRX Operating marginTCRX Operating cash flowTCRX Free cash flowTCRX Capital expendituresTCRX Return on equityTCRX Stock buybacksTCRX Dividends paidTCRX Total assetsTCRX Total liabilitiesTCRX Shareholders’ equityTCRX overview →